JP2024099628A5 - - Google Patents

Download PDF

Info

Publication number
JP2024099628A5
JP2024099628A5 JP2024066182A JP2024066182A JP2024099628A5 JP 2024099628 A5 JP2024099628 A5 JP 2024099628A5 JP 2024066182 A JP2024066182 A JP 2024066182A JP 2024066182 A JP2024066182 A JP 2024066182A JP 2024099628 A5 JP2024099628 A5 JP 2024099628A5
Authority
JP
Japan
Prior art keywords
pharmaceutical formulation
concentration
mannitol
excipient
lyophilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024066182A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024099628A (ja
Filing date
Publication date
Priority claimed from CN201410002665.6A external-priority patent/CN104758922A/zh
Application filed filed Critical
Publication of JP2024099628A publication Critical patent/JP2024099628A/ja
Publication of JP2024099628A5 publication Critical patent/JP2024099628A5/ja
Pending legal-status Critical Current

Links

JP2024066182A 2014-01-03 2024-04-16 ニューレグリン調合剤の処方 Pending JP2024099628A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN201410002665.6 2014-01-03
CN201410002665.6A CN104758922A (zh) 2014-01-03 2014-01-03 纽兰格林制剂的配方
JP2020082456A JP7100083B2 (ja) 2014-01-03 2020-05-08 ニューレグリン調合剤の処方
JP2022105452A JP7479068B2 (ja) 2014-01-03 2022-06-30 ニューレグリン調合剤の処方

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022105452A Division JP7479068B2 (ja) 2014-01-03 2022-06-30 ニューレグリン調合剤の処方

Publications (2)

Publication Number Publication Date
JP2024099628A JP2024099628A (ja) 2024-07-25
JP2024099628A5 true JP2024099628A5 (enExample) 2024-10-08

Family

ID=53493186

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016544419A Active JP6703483B2 (ja) 2014-01-03 2014-12-17 ニューレグリン調合剤の処方
JP2020082456A Active JP7100083B2 (ja) 2014-01-03 2020-05-08 ニューレグリン調合剤の処方
JP2022105452A Active JP7479068B2 (ja) 2014-01-03 2022-06-30 ニューレグリン調合剤の処方
JP2024066182A Pending JP2024099628A (ja) 2014-01-03 2024-04-16 ニューレグリン調合剤の処方

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2016544419A Active JP6703483B2 (ja) 2014-01-03 2014-12-17 ニューレグリン調合剤の処方
JP2020082456A Active JP7100083B2 (ja) 2014-01-03 2020-05-08 ニューレグリン調合剤の処方
JP2022105452A Active JP7479068B2 (ja) 2014-01-03 2022-06-30 ニューレグリン調合剤の処方

Country Status (10)

Country Link
US (3) US10702585B2 (enExample)
EP (2) EP3090756B2 (enExample)
JP (4) JP6703483B2 (enExample)
KR (3) KR20160105443A (enExample)
CN (4) CN110946993A (enExample)
AU (1) AU2014375637A1 (enExample)
BR (1) BR112016015660A2 (enExample)
CA (1) CA2935607A1 (enExample)
RU (1) RU2738158C2 (enExample)
WO (1) WO2015101182A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3363455A1 (en) 2005-12-30 2018-08-22 Zensun (Shanghai) Science & Technology, Co., Ltd. Extended release of neuregulin for improved cardiac function
JP6096262B2 (ja) 2009-08-25 2017-03-15 ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． ニューレグリンに基づく心不全の治療方法
CN102139095A (zh) 2010-01-29 2011-08-03 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
RU2650962C2 (ru) 2012-06-07 2018-04-18 Чилдрен'З Хоспитал Лос Анджелес Способы лечения нейтропении с применением ретиноидных агонистов
CN109276705B (zh) 2012-10-08 2023-10-20 上海泽生科技开发股份有限公司 治疗糖尿病患者心力衰竭的组份和方法
BR112015029293A2 (pt) 2013-05-22 2018-04-24 Zensun Shanghai Science & Tech Ltd método e kit para prevenir, tratar ou retardar uma doença ou distúrbio cardiovascular em um mamífero
CN110946993A (zh) 2014-01-03 2020-04-03 上海泽生科技开发股份有限公司 纽兰格林制剂的配方
CN105497876B (zh) 2014-09-24 2021-01-15 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物
CN105561298A (zh) 2014-10-17 2016-05-11 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物
CN113166218B (zh) 2018-04-11 2024-08-13 信立泰生物医药公司 人神经调节蛋白-1(nrg-1)重组融合蛋白组合物和其使用方法
AR121035A1 (es) 2019-04-01 2022-04-13 Lilly Co Eli Compuestos de neuregulina-4 y métodos de uso
US20230057622A1 (en) * 2019-09-16 2023-02-23 Zensun (Shanghai) Science & Technology, Co., Ltd. Recombinant Human Neuregulin Derivatives and Use Thereof
JP7425459B2 (ja) * 2019-10-11 2024-01-31 株式会社シノテスト 安定化されたｈｍｇｂ１含有溶液
WO2021126882A1 (en) * 2019-12-16 2021-06-24 Seagen Inc. High performance liquid chromatography quantification of excipients

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989001489A1 (en) 1987-08-10 1989-02-23 Commonwealth Scientific And Industrial Research Or Control of angiogenesis and compositions and methods therefor
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US7115554B1 (en) 1993-05-06 2006-10-03 Acorda Therapeutics, Inc. Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III
US5834229A (en) 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US6750196B1 (en) 1995-03-27 2004-06-15 Acorda Therapeutics Methods of treating disorders of the eye
US5912326A (en) 1995-09-08 1999-06-15 President And Fellows Of Harvard College Cerebellum-derived growth factors
AU732027B2 (en) 1997-02-10 2001-04-12 Genentech Inc. Heregulin variants
KR20010031103A (ko) 1997-10-14 2001-04-16 버틀러 그레고리 비. 네우레굴린을 사용하는 치료요법적 방법
US6054261A (en) 1998-05-20 2000-04-25 Q-Pharma, Inc. Coenzyme Q10 compositions for organ protection during perfusion
AUPP785098A0 (en) 1998-12-21 1999-01-21 Victor Chang Cardiac Research Institute, The Treatment of heart disease
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
CN1138785C (zh) 1999-06-04 2004-02-18 周明东 生长因子神经调节蛋白及其类似物的新应用
AUPQ105799A0 (en) 1999-06-18 1999-07-08 Victor Chang Cardiac Research Institute, The Cell growth inhibition
CN1423696A (zh) 2000-02-28 2003-06-11 解码遗传Ehf公司 人类精神分裂症基因
CA2409996C (en) * 2000-05-23 2016-03-01 Cenes Pharmaceuticals, Inc. Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
WO2002024889A2 (en) 2000-09-12 2002-03-28 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Optimized cardiac contraction through differential phosphorylation of myosin
US6482624B2 (en) 2000-11-14 2002-11-19 Pe Corporation (Ny) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
RU2180843C1 (ru) 2001-02-19 2002-03-27 Новокузнецкий государственный институт усовершенствования врачей Способ профилактики повторного инфаркта миокарда
DE10124387A1 (de) * 2001-05-18 2002-11-28 Basf Ag Hydrophob modifizierte Polyethylenimine und Polyvinylamine zur Antiknitterausrüstung von cellulosehaltigen Textilien
CN1498656A (zh) 2002-11-08 2004-05-26 上海泽生科技开发有限公司 神经调节蛋白用于心肌梗死治疗的方法和组合物
WO2003099320A1 (en) 2002-05-24 2003-12-04 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
EP1573045A4 (en) 2002-11-27 2007-02-21 Artesian Therapeutics Inc DETECTION OF GENES RELATED TO HEART FAILURE AND THERAPEUTIC ASSAY
US20050112128A1 (en) 2003-05-21 2005-05-26 Myogen, Inc. And Board Of Regents, The University Of Texas System Inhibition of protein kinase c-mu (PKD) as a treatment for cardiac hypertrophy and heart failure
GB0413005D0 (en) 2004-06-11 2004-07-14 Coletica Ligand
US20080213395A1 (en) 2004-10-14 2008-09-04 Adventures Plus Pty Ltd Method for the Treatment of Gastrointestinal and Other Disorders with an Admixture of Vitamins
US20060160062A1 (en) 2005-01-14 2006-07-20 Young Lindon H Perfusion and/or preservation solution for organs
DE602006017071D1 (de) * 2005-01-25 2010-11-04 Five Prime Therapeutics Inc Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
US20070141548A1 (en) 2005-03-11 2007-06-21 Jorg Kohl Organ transplant solutions and method for transplanting organs
CN100361709C (zh) 2005-08-30 2008-01-16 山东省生物药物研究院 一种对生命活性物质有保护作用的糖类组合
CN1768859A (zh) 2005-10-24 2006-05-10 天津大学 基于醛基的微粒表面多重生物功能因子组装方法
US20070213264A1 (en) 2005-12-02 2007-09-13 Mingdong Zhou Neuregulin variants and methods of screening and using thereof
CN101394861A (zh) * 2005-12-30 2009-03-25 上海泽生科技开发有限公司 纽兰格林持续给药能改善心脏功能
EP3363455A1 (en) * 2005-12-30 2018-08-22 Zensun (Shanghai) Science & Technology, Co., Ltd. Extended release of neuregulin for improved cardiac function
EP1876227B2 (en) * 2006-07-07 2020-08-12 The Procter and Gamble Company Detergent Compositions
US9580515B2 (en) 2006-08-21 2017-02-28 Zensun (Shanghai) Science & Technology, Co., Ltd. Neukinase, a downstream protein of neuregulin
DK2115477T3 (en) 2007-01-25 2015-08-10 Hoffmann La Roche USE OF IGFBP-7 IN THE EVIDENCE OF HEART FAILURE
CN101310779A (zh) 2007-05-25 2008-11-26 上海泽生科技开发有限公司 包含神经调节蛋白的装置及药物制剂
CN101310766B (zh) 2007-05-25 2014-04-16 上海泽生科技开发有限公司 神经调节蛋白的新用途
US20090156488A1 (en) 2007-09-12 2009-06-18 Zensun (Shanghai) Science & Technology Limited Use of neuregulin for organ preservation
US20110212108A1 (en) 2008-05-09 2011-09-01 The Regents Of The University Of California Neuregulin/erbb signaling and integrin
AU2009292216B2 (en) 2008-07-17 2015-03-05 Acorda Therapeutics, Inc. Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
JP2012509908A (ja) * 2008-11-28 2012-04-26 ゼンサン （シャンハイ） サイエンス アンド テクノロジー リミテッド ニューレグリン及び心臓幹細胞
WO2010060265A1 (en) * 2008-11-28 2010-06-03 Zensun (Shanghai) Science & Technology Limited Neuregulin peptides and their use
EP2440236B1 (en) 2009-06-09 2016-05-04 Zensun (Shanghai) Science and Technology Limited Neuregulin based methods for treating heart failure
ES2748886T3 (es) 2009-06-09 2020-03-18 Zensun Shanghai Science & Tech Co Ltd Métodos basados en Neuregulina para el tratamiento de la insuficiencia cardíaca
JP6096262B2 (ja) 2009-08-25 2017-03-15 ゼンサン （シャンハイ） サイエンス アンド テクノロジー，シーオー．，エルティーディー． ニューレグリンに基づく心不全の治療方法
CN102139095A (zh) 2010-01-29 2011-08-03 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
ES2637072T3 (es) 2010-03-10 2017-10-10 Cempra Pharmaceuticals, Inc. Formulación parenteral de antibióticos macrólidos
US9029328B2 (en) 2010-03-24 2015-05-12 The Brigham And Women's Hospital, Inc. Methods for cardioprotection and cardioregeneration with dimers of EGF family ligands
CA2989896C (en) 2010-07-22 2021-02-09 Reven Pharmaceuticals, Inc. Methods of treating or ameliorating diseases and enhancing performance comprising the use of a magnetic dipole stabilized solution
CN102230084B (zh) * 2011-06-14 2013-01-23 东北大学 低品位含砷难浸金矿的包覆生物氧化预处理方法
WO2013053076A1 (en) 2011-10-10 2013-04-18 Zensun （Shanghai）Science & Technology Limited Compositions and methods for treating heart failure
AU2013243952A1 (en) * 2012-04-02 2014-10-30 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
CN109276705B (zh) 2012-10-08 2023-10-20 上海泽生科技开发股份有限公司 治疗糖尿病患者心力衰竭的组份和方法
EP2964249A1 (en) * 2013-03-06 2016-01-13 Acorda Therapeutics, Inc. Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure
BR112015029293A2 (pt) 2013-05-22 2018-04-24 Zensun Shanghai Science & Tech Ltd método e kit para prevenir, tratar ou retardar uma doença ou distúrbio cardiovascular em um mamífero
CN104337813A (zh) 2013-07-23 2015-02-11 上海泽生科技开发有限公司 使用维生素b组合物促进胃肠系统动力的方法
CN104758300A (zh) 2014-01-02 2015-07-08 上海泽生科技开发有限公司 维生素d及其组合物的抗菌用途
CN110946993A (zh) 2014-01-03 2020-04-03 上海泽生科技开发股份有限公司 纽兰格林制剂的配方
CN105497876B (zh) 2014-09-24 2021-01-15 上海泽生科技开发股份有限公司 神经调节蛋白用于预防、治疗或延迟心脏室性心律失常的方法和组合物
CN105561298A (zh) 2014-10-17 2016-05-11 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物

Similar Documents

Publication Publication Date Title
JP2024099628A5 (enExample)
JP2022130627A5 (enExample)
ES2286868T3 (es) Composicion acuosa a base de hormana del crecimiento humana.
CN1523997B (zh) 稳定的白介素2
TWI593421B (zh) 凍乾的重組ｖｗｆ調配物
ES2363272T3 (es) Formulaciones de la hormona paratiroidea y utilizaciones de la misma.
JP5753692B2 (ja) タンパク質製剤
KR100457485B1 (ko) 안정한 트란스글루타미나제 제형 및 이의 제조 방법
US20110269685A1 (en) Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
NO327302B1 (no) Lagringsstabil sammensetning, forseglet ror eller patron inneholdende nevnte sammensetning samt fremgangsmate for deres fremstilling
KR100705997B1 (ko) 안정화된 hgf 동결건조제제 및 그 제조방법
US20240041977A1 (en) Annexin a1 n-terminal peptide formulations and methods
US20250215054A1 (en) Compositions and methods for treatment of fungal infections
ES3019509T3 (en) Pharmaceutical composition of glp-1/glp-2 dual agonists
JP2025121987A (ja) Ｇｌｐ－１／ｇｌｐ－２デュアルアゴニストの医薬組成物
CN105451756A (zh) 在治疗马凡氏综合征及其相关病症中的血管紧张素肽
US6497869B2 (en) Stabilized granulocyte colony stimulating factor
AU2014237111B2 (en) Recombinant factor VIII formulations
BR112012010392B1 (pt) composição e kit para o inibidor de alfa-1 proteinase
JPH06247872A (ja) 高濃度ｔｃｆ製剤
US5861481A (en) Peptide lung surfactants and therapeutic combinations
IE903479A1 (en) Stabilized Leukocyte-Interferons
US12012440B2 (en) Compositions and methods for treatment of fungal infections
JPH07291874A (ja) ヘパリン中和剤
AU3541900A (en) Stable transglutaminase preparations and process for producing them